Page results
-
OPAT (Outpatient Parenteral Antimicrobial Therapy) is a safe and convenient way to receive intravenous (IV) antibiotic therapy at home or in a clinic.
-
Advice on eating better for young people living with fatigue-related conditions such as CFS and ME.
-
This information has been written to prepare you for your hospital stay.
-
ME/CFS is a condition where chronic fatigue is not, much relieved by rest. It affects daily functioning and may also trigger joint pains, mood and sleep disturbance, concentration difficulties, headaches, intestinal and urinary symptoms.
-
The UCLH Bariatric Centre for Weight Management and Metabolic Surgery is one of the largest obesity and bariatric centres in the county, with an international reputation for the quality and expertise of our clinical service, our research and the clinical training that we provide.
-
Information about the integrated physiotherapy service at the Royal London Hospital for Integrated Medicine.
-
This information describes the different types of anaesthetic you might require for your operation.
-
The Macmillan Support and Information Service have developed an online programme of workshops and videos. These give advice to support people who have cancer or a blood condition to manage well from diagnosis onwards.
-
Learn more about the Spectra Optia Funding to Deliver More Apheresis Capacity for Patients
File results
-
FOI/2024/0371 - Acute myeloid leukaemia treatment
-
FOI/2024/0365 - Specialist clinical systems to manage patients and patient clinical notes
-
FOI/2024/0363 - Freedom of Information responses available for Mesh requests
-
FOI/2024/0530 - Radiology/ imaging examinations/ patient access to radiology images
-
FOI/2024/0520 - Treatment of melanoma
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0527 - Treatment for renal cell carcinoma
-
FOI/2024/0528 - Open MRIs referrals for patient size/ spend on specialist bariatric equipment 2017-2024
-
FOI/2024/0529 - Medical Associate Professionals (MAPs) at Trust
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer